JEADVObservational studyLetter
Role of disease duration, bio-naivety, MoA and BMI in predicting PASI 100 under biologic therapy.
Looser R, Steybe TM, Simmler P, Wedel MA, Spínola MA, Greis C, Maul LV, Heidemeyer K, Yawalkar N, Cozzio A, Conrad C, Boehncke WH, Kündig T, Maul JT, Navarini AA
Journal of the European Academy of Dermatology and VenereologyIn the feed 12 Oct 2026, published online 12 Oct 2026, issue 2026 Oct 12, added to PubMed 12 Oct 2026
Topics: Psoriasis
Abstract
PubMed has no abstract for this paper, as is usual for research letters, correspondence and editorials. The publisher’s page has the full paper.
PMID 42861911 · DOI 10.1111/jdv.70746